McLellan A R, Connell J M, Beastall G H, Teasdale G, Davies D L
Department of Medicine, Western Infirmary, Glasgow.
Q J Med. 1988 Dec;69(260):997-1008.
Acromegaly is associated with abnormal indices of body composition (as determined by exchangeable sodium, exchangeable potassium and total body water estimations) which may be corrected by treatment. We related these indices of body composition to the attained growth hormone levels (mean of five daytime values) in 42 treated acromegalics. Somatomedin C was measured in 30 subjects. The mean duration of treatment was 7.7 years (range 1-26). Exchangeable sodium, potassium and total body water were significantly lowered by treatment. After treatment of acromegaly subjects whose growth hormone level was below 5 mU/l achieved normal body composition more often than those with higher levels. Growth hormone concentration of below 5 mU/l after treatment should be regarded as more appropriate index of control of acromegaly than the higher levels previously recommended.
肢端肥大症与身体成分异常指标相关(通过可交换钠、可交换钾和总体水估计确定),这些指标可通过治疗得到纠正。我们将这些身体成分指标与42例接受治疗的肢端肥大症患者达到的生长激素水平(五个日间值的平均值)相关联。对30名受试者测量了生长调节素C。平均治疗持续时间为7.7年(范围1 - 26年)。治疗后可交换钠、钾和总体水显著降低。肢端肥大症患者治疗后生长激素水平低于5 mU/l者比水平较高者更常实现正常身体成分。治疗后生长激素浓度低于5 mU/l应被视为比先前推荐的较高水平更合适的肢端肥大症控制指标。